|
|
| 37.39 Data as of Apr 17 |  +0.39 / +1.05%Today’s Change | 19.10 Today|||52-Week Range 38.60 | +29.60% Year-to-Date |
| Previous close | 37.00 |
| Today’s open | 36.79 |
| Day’s range | 36.65 - 37.39 |
| Volume | 6,738 |
| Average volume (3 months) | 19,142 |
| Market cap | $857.6M |
| Dividend yield | -- |
| Earnings growth (last year) | +18.50% |
| Earnings growth (this year) | +20.41% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +10.03% |
| P/E ratio | 13.8 |
| Price/Sales | 3.75 |
| Price/Book | 3.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| ECYTEndocyte Inc | -0.50 | -2.68% |
| FURXFuriex Pharmaceutica... | -1.88 | -2.44% |
| SRPTSarepta Therapeutics... | +0.17 | +0.70% |
| EBSEmergent BioSolution... | +0.34 | +1.35% |
| Next reporting date | May 19, 2014 |
| EPS forecast (this quarter) | $0.53 |
| Annual revenue (last year) | $203.4M |
| Annual profit (last year) | $54.1M |
| Net profit margin | 26.63% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO David Xiaoying Gao |
CFO, Treasurer & Vice President-Compliance Ming Yang |
Corporate headquarters Beijing, Beijing |
.
